cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.hp8rzk
title: Occurrence Download

description: A dataset containing 146526 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Geometry POLYGON ((5.373486 51.3876, 5.537247 51.3876, 5.537247 51.51316, 5.373486 51.51316, 5.373486 51.3876))",
 "Year is greater than or equal to 2013",
 "HasGeospatialIssue is false",
 "TaxonKey is Aves",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen, Specimen)"
 ]
 }
 }
 ]
}

 The dataset includes 146526 records from 10 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007628-241024112534372/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5883/bold:aaa8426
title: Overview of Barcode Index Number - BOLD:AAA8426

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8427
title: Barcode Index Number BOLD:AAA8427

description: A cluster of barcode records associated with a Barcode Index Number(BIN). Each cluster is a proxy for a named or unnamed species. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8429
title: Barcode Index Number BOLD:AAA8429

description: A cluster of barcode records associated with a Barcode Index Number(BIN). Each cluster is a proxy for a named or unnamed species. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8431
title: Overview of Barcode Index Number - BOLD:AAA8431

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8432
title: Overview of Barcode Index Number - BOLD:AAA8432

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8434
title: Overview of Barcode Index Number - BOLD:AAA8434

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8435
title: Overview of Barcode Index Number - BOLD:AAA8435

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8436
title: Overview of Barcode Index Number - BOLD:AAA8436

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8438
title: Overview of Barcode Index Number - BOLD:AAA8438

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8439
title: Overview of Barcode Index Number - BOLD:AAA8439

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8440
title: Overview of Barcode Index Number - BOLD:AAA8440

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8441
title: Overview of Barcode Index Number - BOLD:AAA8441

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8442
title: Overview of Barcode Index Number - BOLD:AAA8442

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8445
title: Overview of Barcode Index Number - BOLD:AAA8445

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8446
title: Overview of Barcode Index Number - BOLD:AAA8446

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8447
title: Barcode Index Number BOLD:AAA8447

description: A cluster of barcode records associated with a Barcode Index Number(BIN). Each cluster is a proxy for a named or unnamed species. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8449
title: Barcode Index Number BOLD:AAA8449

description: A cluster of barcode records associated with a Barcode Index Number(BIN). Each cluster is a proxy for a named or unnamed species. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8450
title: Overview of Barcode Index Number - BOLD:AAA8450

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8451
title: Overview of Barcode Index Number - BOLD:AAA8451

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8452
title: Overview of Barcode Index Number - BOLD:AAA8452

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8453
title: Overview of Barcode Index Number - BOLD:AAA8453

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8454
title: Overview of Barcode Index Number - BOLD:AAA8454

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.5883/bold:aaa8455
title: Overview of Barcode Index Number - BOLD:AAA8455

description: DNA barcode data hosted in the Data Portal of the Barcode of Life Data Systems. Records consist of specimen metadata, specimen images, and sequence data.
DOI: 10.15468/dl.3bjtzn
title: Occurrence Download

description: A dataset containing 5 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Bartsia trixago",
 "Country is Chile",
 "HasCoordinate is true"
 ]
}

 The dataset includes 5 records from 4 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0014892-250914085247600/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.w77k9q
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Bartsia trixago",
 "Country is Austria",
 "HasCoordinate is true"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0014891-250914085247600/datasets/export for details.
DOI: 10.15468/dl.sz6gpf
title: Occurrence Download

description: A dataset containing 43746 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is China",
 "HasCoordinate is true",
 "Year is 2009"
 ]
}

 The dataset includes 43746 records from 231 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0014896-250914085247600/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.jamka5
title: Occurrence Download

description: A dataset containing 11365 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is France",
 "TaxonKey is Rhamnus saxatilis"
 ]
}

 The dataset includes 11365 records from 184 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0014898-250914085247600/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.xerjc6
title: Occurrence Download

description: A dataset containing 3 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Mimulus moschatus",
 "Country is Austria",
 "HasCoordinate is true"
 ]
}

 The dataset includes 3 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0014901-250914085247600/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.17026/ls/npjbpn
title: Data underlying the research article "Ground-lying deadwood volume promotes soil beta diversity but not alpha diversity in European temperate forests"

description: Dataset for: "Ground-lying deadwood volume promotes soil beta diversity but not alpha diversity in European temperate forests". The manuscript was published in Plant and Soil in May 2025.
DOI: 10.57745/bcql5y
title: readme.txt

description: :unav
DOI: 10.57745/o5f0fx
title: 2_processed_data.zip

description: :unav
DOI: 10.57745/tpihcw
title: 1_pre_processed_data.zip

description: :unav
DOI: 10.57745/cjpb9j
title: 0_raw_data.zip

description: :unav
DOI: 10.57745/juuhq3
title: readme.txt

description: New version of README file, added 3_sample_data.
DOI: 10.57745/fgbyi5
title: 3_sample_data.zip

description: Sample data for use in DATTES demo.
DOI: 10.57745/g02iye
title: Characterisation tests of LFP 105Ah cells

description: This dataset contains characterization measurements that were performed at the University Gustave Eiffel by Pedro Von Hohendorff Seger under the supervision of Eduardo Redondo-Iglesias (eduardo.redondo@univ-eiffel.fr). Four 105 Ah LFP cells were tested in a thermal chamber with a Biologic BCS 815 cycler.
DOI: 10.6084/m9.figshare.30156994
title: Supplementary Material for: A New t(8;9) Translocation Involving the JAK2 Gene in Acute Myeloid Leukemia: a Case Report

description: Abstract
Introduction: Acute myeloid leukemia (AML) is a molecularly and clinically heterogeneous disease. Nearly 50% of patients exhibit a normal karyotype, although genomic aberrations are recurrent. Translocations involving JAK2 have increasingly been identified in patients with JAK2V617F-negative myeloproliferative neoplasms (MPNs), as well as in various other hematologic diseases. Here, we present a unique case of a de novo AML patient with a t(8;9)(p22;p24) translocation, resulting in HMBOX1::JAK2 fusion. 
Case presentation: The patient exhibited anemia, leukocytosis, and thrombocytopenia, with bone marrow analysis revealing a significant population of CD34+CD33+ myeloid blasts. The conventional cytogenetic analysis initially showed a normal karyotype, later identifying the t(8;9) translocation after relapse. Molecular characterization of the translocation allowed us to delineate the breakpoints regions, which map to exon 5 of the HMBOX1 gene and exon 19 of the JAK2 gene. The resulting transcript was an in-frame fusion. The patient was diagnosed with acute monocytic leukemia. Induction chemotherapy (cytarabine and idarubicin) initially achieved remission, but subsequent relapses led to the use of venetoclax and 5-azacytidine, which again resulted in remission. Unfortunately, disease progression followed, and the patient ultimately succumbed to AML.
Conclusion: This is the first report that molecularly characterize the HMBOX1::JAK2 fusion in a de novo AML patient. The identification of this novel alteration adds to the growing and heterogeneous molecular landscape of AML and suggests a potential new avenue for targeted therapy.
DOI: 10.6084/m9.figshare.30156994.v1
title: Supplementary Material for: A New t(8;9) Translocation Involving the JAK2 Gene in Acute Myeloid Leukemia: a Case Report

description: Abstract
Introduction: Acute myeloid leukemia (AML) is a molecularly and clinically heterogeneous disease. Nearly 50% of patients exhibit a normal karyotype, although genomic aberrations are recurrent. Translocations involving JAK2 have increasingly been identified in patients with JAK2V617F-negative myeloproliferative neoplasms (MPNs), as well as in various other hematologic diseases. Here, we present a unique case of a de novo AML patient with a t(8;9)(p22;p24) translocation, resulting in HMBOX1::JAK2 fusion. 
Case presentation: The patient exhibited anemia, leukocytosis, and thrombocytopenia, with bone marrow analysis revealing a significant population of CD34+CD33+ myeloid blasts. The conventional cytogenetic analysis initially showed a normal karyotype, later identifying the t(8;9) translocation after relapse. Molecular characterization of the translocation allowed us to delineate the breakpoints regions, which map to exon 5 of the HMBOX1 gene and exon 19 of the JAK2 gene. The resulting transcript was an in-frame fusion. The patient was diagnosed with acute monocytic leukemia. Induction chemotherapy (cytarabine and idarubicin) initially achieved remission, but subsequent relapses led to the use of venetoclax and 5-azacytidine, which again resulted in remission. Unfortunately, disease progression followed, and the patient ultimately succumbed to AML.
Conclusion: This is the first report that molecularly characterize the HMBOX1::JAK2 fusion in a de novo AML patient. The identification of this novel alteration adds to the growing and heterogeneous molecular landscape of AML and suggests a potential new avenue for targeted therapy.
DOI: 10.6084/m9.figshare.30156997.v1
title: Supplementary Material from Australia’s First Peoples: hunters of extinct megafauna or Australia’s first fossil collectors

description: ESM Table S1_25 July 25.xlsx
DOI: 10.6084/m9.figshare.30156997
title: Supplementary Material from Australia’s First Peoples: hunters of extinct megafauna or Australia’s first fossil collectors

description: ESM Table S1_25 July 25.xlsx
DOI: 10.6084/m9.figshare.30157003
title: Supplementary Material for: Effects of 12 Weeks of Whole body Vibration Training and Vitamin D Supplementation on Bone Density and Muscle Quality in the aged with osteosarcopenia: a randomized controlled trial

description: Introduction: Osteosarcopenia (OS) is a common geriatric condition, which seriously impairs the quality of life of the elderly, but there is a lack of research on its mechanism and treatment. This study explores the efficacy of whole body vibration (WBV) training plus vitamin D in OS intervention and its correlation with irisin and myostatin. 
Methods: Subjects meeting the enrollment criteria were recruited from the Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine. 48 volunteers were enrolled and divided into a control group and a WBVT group, with 24 in each. The control group takes 0.25 μg of calcitriol orally half an hour after breakfast daily. The WBVT group received WBV training 3 times a week in addition to the control treatment for 3 months, followed by a 3-month follow-up. Primary outcomes were lumbar, hip, and forearm bone mineral density (BMD), appendicular skeletal muscle mass measured by dual energy x-ray absorptiometry, and handgrip strength. Secondary outcomes included serum myostatin, irisin, bone turnover markers, physical performance (assessed by 5-time chair stand test, 6-metre walk, and SPPB), and adverse events in the trial.
Results: Baseline indicators were comparable between the two groups. WBV training with oral vitamin D improved OS patients' BMD, muscle mass, strength, and physical function. It increased serum vitamin D, N-MID, tPINP levels and decreased β-CTX levels. Also, it raised irisin and lowered myostatin levels.
Conclusion: WBV training in conjunction with oral vitamin D administration is conducive to increasing BMD, augmenting muscle mass and strength, as well as improving body function in subjects with OS. The underlying mechanism might be associated with the modulation of myokines such as irisin and myostatin.
DOI: 10.6084/m9.figshare.30157003.v1
title: Supplementary Material for: Effects of 12 Weeks of Whole body Vibration Training and Vitamin D Supplementation on Bone Density and Muscle Quality in the aged with osteosarcopenia: a randomized controlled trial

description: Introduction: Osteosarcopenia (OS) is a common geriatric condition, which seriously impairs the quality of life of the elderly, but there is a lack of research on its mechanism and treatment. This study explores the efficacy of whole body vibration (WBV) training plus vitamin D in OS intervention and its correlation with irisin and myostatin. 
Methods: Subjects meeting the enrollment criteria were recruited from the Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine. 48 volunteers were enrolled and divided into a control group and a WBVT group, with 24 in each. The control group takes 0.25 μg of calcitriol orally half an hour after breakfast daily. The WBVT group received WBV training 3 times a week in addition to the control treatment for 3 months, followed by a 3-month follow-up. Primary outcomes were lumbar, hip, and forearm bone mineral density (BMD), appendicular skeletal muscle mass measured by dual energy x-ray absorptiometry, and handgrip strength. Secondary outcomes included serum myostatin, irisin, bone turnover markers, physical performance (assessed by 5-time chair stand test, 6-metre walk, and SPPB), and adverse events in the trial.
Results: Baseline indicators were comparable between the two groups. WBV training with oral vitamin D improved OS patients' BMD, muscle mass, strength, and physical function. It increased serum vitamin D, N-MID, tPINP levels and decreased β-CTX levels. Also, it raised irisin and lowered myostatin levels.
Conclusion: WBV training in conjunction with oral vitamin D administration is conducive to increasing BMD, augmenting muscle mass and strength, as well as improving body function in subjects with OS. The underlying mechanism might be associated with the modulation of myokines such as irisin and myostatin.
DOI: 10.6084/m9.figshare.30157006
title: Supplementary Material from Australia’s First Peoples: hunters of extinct megafauna or Australia’s first fossil collectors

description: ESM Table S2_XRF 2_25 July 25.xlsx
DOI: 10.6084/m9.figshare.30157006.v1
title: Supplementary Material from Australia’s First Peoples: hunters of extinct megafauna or Australia’s first fossil collectors

description: ESM Table S2_XRF 2_25 July 25.xlsx
DOI: 10.21227/0kkj-cm49
title: "ToF Displacement Dataset for Lung Function Measurements"

description: "This supplementary dataset contains the demographic data and respiratory parameters used in the study \u201cTime-of-Flight Abdominal Wall Displacement for Non-Invasive Longitudinal Monitoring of Pulmonary Function\u201d. The dataset is provided below.  Data were collected from 28 healthy volunteers for MVV and VC and from 31 subjects for FVC measurements. "
DOI: 10.5519/qd.xgdw3z9r
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (5504 records)
DOI: 10.6084/m9.figshare.30157012
title: Supplementary Material for: Outcomes of Therapeutic Endoscopic Retrograde Cholangiopancreatography in Elderly Patients (≥80 Years) with Choledocholithiasis: A Comprehensive Meta-Analysis

description: Background: Endoscopic retrograde cholangiopancreatography (ERCP) is the standard treatment for choledocholithiasis. However, elderly patients, particularly those aged ≥80 and ≥90, may face higher risks of complications due to comorbidities and age-related anatomical changes. This meta-analysis aimed to evaluate efficacy and safety of ERCP in this population. 
Methods: A systematic search yielded 17 retrospective studies. Data were synthesized using both single-arm and comparative analyses, with subgroup analyses focusing on nonagenarians (≥90 years). Outcomes assessed included complete stone clearance, cannulation success, adverse events (AEs), sedation strategies, and biliary stent use. 
Results: The pooled stone clearance rate was 77% in patients ≥80 and 65% in nonagenarians. When multiple ERCP sessions were employed, clearance rates increased to 84% in patients aged ≥80 and 82% in nonagenarians, compared with 61% and 38%, respectively, for single-session procedures. The pooled AEs rate was 8% in patients ≥80 and 6% in those ≥90, with ERCP-related mortality between 0% and 1%. Complete clearance was significantly lower in patients aged ≥80 versus those aged &lt;80 (OR = 0.41; P = 0.003), and in patients aged ≥90 versus those aged &lt;90 (OR = 0.30; P = 0.047), while cannulation success and AEs was similar. Additionally, elderly patients were more likely to receive general anesthesia (OR = 7.08, P &lt; 0.001) and biliary stenting (OR = 2.78; P = 0.002), with permanent stents used more frequently (OR = 15.66, P &lt; 0.001). Nonagenarians experienced higher cardiopulmonary risks (OR = 4.60; P = 0.042). 
Discussion: ERCP is effective and safe for elderly patients, though age-related challenges necessitate tailored approaches. Staged procedures and age-adjusted sedation can mitigate risks. While permanent stenting offers palliative utility, long-term monitoring is essential to address late complications.
DOI: 10.6084/m9.figshare.30157012.v1
title: Supplementary Material for: Outcomes of Therapeutic Endoscopic Retrograde Cholangiopancreatography in Elderly Patients (≥80 Years) with Choledocholithiasis: A Comprehensive Meta-Analysis

description: Background: Endoscopic retrograde cholangiopancreatography (ERCP) is the standard treatment for choledocholithiasis. However, elderly patients, particularly those aged ≥80 and ≥90, may face higher risks of complications due to comorbidities and age-related anatomical changes. This meta-analysis aimed to evaluate efficacy and safety of ERCP in this population. 
Methods: A systematic search yielded 17 retrospective studies. Data were synthesized using both single-arm and comparative analyses, with subgroup analyses focusing on nonagenarians (≥90 years). Outcomes assessed included complete stone clearance, cannulation success, adverse events (AEs), sedation strategies, and biliary stent use. 
Results: The pooled stone clearance rate was 77% in patients ≥80 and 65% in nonagenarians. When multiple ERCP sessions were employed, clearance rates increased to 84% in patients aged ≥80 and 82% in nonagenarians, compared with 61% and 38%, respectively, for single-session procedures. The pooled AEs rate was 8% in patients ≥80 and 6% in those ≥90, with ERCP-related mortality between 0% and 1%. Complete clearance was significantly lower in patients aged ≥80 versus those aged &lt;80 (OR = 0.41; P = 0.003), and in patients aged ≥90 versus those aged &lt;90 (OR = 0.30; P = 0.047), while cannulation success and AEs was similar. Additionally, elderly patients were more likely to receive general anesthesia (OR = 7.08, P &lt; 0.001) and biliary stenting (OR = 2.78; P = 0.002), with permanent stents used more frequently (OR = 15.66, P &lt; 0.001). Nonagenarians experienced higher cardiopulmonary risks (OR = 4.60; P = 0.042). 
Discussion: ERCP is effective and safe for elderly patients, though age-related challenges necessitate tailored approaches. Staged procedures and age-adjusted sedation can mitigate risks. While permanent stenting offers palliative utility, long-term monitoring is essential to address late complications.